These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9453271)

  • 1. Differential distribution of 5HT1D- and 5HT1B-immunoreactivity within the human trigemino-cerebrovascular system: implications for the discovery of new antimigraine drugs.
    Longmore J; Shaw D; Smith D; Hopkins R; McAllister G; Pickard JD; Sirinathsinghji DJ; Butler AJ; Hill RG
    Cephalalgia; 1997 Dec; 17(8):833-42. PubMed ID: 9453271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of more and less lipophilic serotonin (5HT1B/1D) agonists in a model of trigeminovascular nociception in cat.
    Hoskin KL; Goadsby PJ
    Exp Neurol; 1998 Mar; 150(1):45-51. PubMed ID: 9514827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-clinical pharmacology of zolmitriptan (Zomig; formerly 311C90), a centrally and peripherally acting 5HT1B/1D agonist for migraine.
    Martin GR
    Cephalalgia; 1997 Oct; 17 Suppl 18():4-14. PubMed ID: 9399012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for 5-HT1B/1D receptors mediating the antimigraine effect of sumatriptan and dihydroergotamine.
    Buzzi MG; Moskowitz MA
    Cephalalgia; 1991 Sep; 11(4):165-8. PubMed ID: 1660351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The trigemino-vascular system and migraine.
    Buzzi MG; Moskowitz MA
    Pathol Biol (Paris); 1992 Apr; 40(4):313-7. PubMed ID: 1379707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5HT1B and 5HT1D receptor mRNA differential co-localization with peptide mRNA in the guinea pig trigeminal ganglion.
    Bonaventure P; Voorn P; Luyten WH; Leysen JE
    Neuroreport; 1998 Mar; 9(4):641-5. PubMed ID: 9559931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The mode of action of sumatriptan is vascular? A debate.
    Humphrey PP; Goadsby PJ
    Cephalalgia; 1994 Dec; 14(6):401-10; discussion 393. PubMed ID: 7697699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of a serotonin agonist (sumatriptan) on the peptidergic innervation of the rat cerebral dura mater and on the expression of c-fos in the caudal trigeminal nucleus in an experimental migraine model.
    Knyihár-Csillik E; Tajti J; Samsam M; Sáry G; Slezák S; Vécsei L
    J Neurosci Res; 1997 Jun; 48(5):449-64. PubMed ID: 9185668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional immunohistochemistry of neuropeptides and nitric oxide synthase in the nerve fibers of the supratentorial dura mater in an experimental migraine model.
    Knyihár-Csillik E; Tajti J; Chadaide Z; Csillik B; Vécsei L
    Microsc Res Tech; 2001 May; 53(3):193-211. PubMed ID: 11301495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-HT1 receptors in migraine pathophysiology and treatment.
    Ferrari MD; Saxena PR
    Eur J Neurol; 1995 Mar; 2(1):5-21. PubMed ID: 24283575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of the 5HT1B/1D receptor agonist naratriptan on trigeminal versus spinal nociceptive responses.
    Cumberbatch MJ; Hill RG; Hargreaves RJ
    Cephalalgia; 1998 Dec; 18(10):659-63. PubMed ID: 9950621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurogenic inflammation in the context of migraine.
    Williamson DJ; Hargreaves RJ
    Microsc Res Tech; 2001 May; 53(3):167-78. PubMed ID: 11301492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intensity dependence of the cortical auditory evoked potentials as a surrogate marker of central nervous system serotonin transmission in man: demonstration of a central effect for the 5HT1B/1D agonist zolmitriptan (311C90, Zomig).
    Proietti-Cecchini A; Afra J; Schoenen J
    Cephalalgia; 1997 Dec; 17(8):849-54; discussion 799. PubMed ID: 9453273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockade of calcitonin gene-related peptide release after superior sagittal sinus stimulation in cat: a comparison of avitriptan and CP122,288.
    Knight YE; Edvinsson L; Goadsby PJ
    Neuropeptides; 1999 Feb; 33(1):41-6. PubMed ID: 10657470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible antimigraine mechanisms of action of the 5HT1F receptor agonist LY334370.
    Shepheard S; Edvinsson L; Cumberbatch M; Williamson D; Mason G; Webb J; Boyce S; Hill R; Hargreaves R
    Cephalalgia; 1999 Dec; 19(10):851-8. PubMed ID: 10668103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential expression of sumatriptan-sensitive 5-hydroxytryptamine receptors in human trigeminal ganglia and cerebral blood vessels.
    Bouchelet I; Cohen Z; Case B; Séguéla P; Hamel E
    Mol Pharmacol; 1996 Aug; 50(2):219-23. PubMed ID: 8700126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Orexin 1 receptor activation attenuates neurogenic dural vasodilation in an animal model of trigeminovascular nociception.
    Holland PR; Akerman S; Goadsby PJ
    J Pharmacol Exp Ther; 2005 Dec; 315(3):1380-5. PubMed ID: 16160082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Present and future of 5-HT receptor agonists as antimigraine drugs.
    Pauwels PJ; John GW
    Clin Neuropharmacol; 1999; 22(3):123-36. PubMed ID: 10367177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonin inhibits trigeminal nucleus activity evoked by craniovascular stimulation through a 5HT1B/1D receptor: a central action in migraine?
    Goadsby PJ; Hoskin KL
    Ann Neurol; 1998 Jun; 43(6):711-8. PubMed ID: 9629840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroeffector functions of sensory fibres: implications for headache mechanisms and drug actions.
    Moskowitz MA; Buzzi MG
    J Neurol; 1991; 238 Suppl 1():S18-22. PubMed ID: 2045826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.